https://www.ksl.com/article/50660032/cancer-vaccines-poised-to-unlock-new-treatment-paradigm-with-merckmoderna-data
An experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread, by 65%, compared to immunotherapy treatment alone, the companies reported on Monday.
Create an account or login to join the discussion